Gabriela Alicia Hernandez-Echaurregui
Overview
Explore the profile of Gabriela Alicia Hernandez-Echaurregui including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
3
Citations
6
Followers
0
Related Specialty
Related Specialty
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Escalante-Bautista D, Cerecedo D, Jimenez-Hernandez E, Gonzalez-Torres C, Gaytan-Cervantes J, Nunez-Enriquez J, et al.
Front Oncol
. 2024 Jan;
13:1276352.
PMID: 38269022
Background: Advances in the understanding of the pathobiology of childhood B-cell acute lymphoblastic leukemia (B-ALL) have led towards risk-oriented treatment regimens and markedly improved survival rates. However, treatment-related toxicities remain...
2.
Valenzuela-Vazquez L, Nunez-Enriquez J, Sanchez-Herrera J, Medina-Sanson A, Perez-Saldivar M, Jimenez-Hernandez E, et al.
Front Oncol
. 2022 Nov;
12:1023510.
PMID: 36419901
NK cells have unique attributes to react towards cells undergoing malignant transformation or viral infection. This reactivity is regulated by activating or inhibitory germline encoded receptors. An impaired NK cell...
3.
May-Hau D, Barcenas-Lopez D, Nunez-Enriquez J, Bekker-Mendez V, Beltran-Anaya F, Jimenez-Hernandez E, et al.
Front Oncol
. 2022 Jun;
12:887766.
PMID: 35719952
Background: B-cell precursor acute lymphoblastic leukemia (BCP-ALL) is the most frequent pediatric cancer worldwide. Despite improvements in treatment regimens, approximately 20% of the cases cannot be cured, highlighting the necessity...